Publication | Closed Access

Screening and evaluation of quality markers from Shuangshen Pingfei formula for idiopathic pulmonary fibrosis using network pharmacology and pharmacodynamic, phytochemical, and pharmacokinetic analyses

Quality MarkersNetwork PharmacologyAntifibrotic TherapyMedicinePulmonary PharmacologyPulmonary FibrosisShuangshen Pingfei FormulaPharmacologyPulmonary Disease